Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00313001
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2006-04-08
Brief Title:
Effects of Biphasic Insulin Aspart 7030 vs Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Organization Data
Organization:
Novo Nordisk AS
Class:
INDUSTRY
Study ID:
BIASP-1714
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novo Nordisk AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None